{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:18:18Z","timestamp":1772759898794,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.humpath.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T11:00:40Z","timestamp":1619262040000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis?"],"prefix":"10.1016","volume":"113","author":[{"given":"Deepika","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omeed","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3845-0798","authenticated-orcid":false,"given":"Dhanpat","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.04.008_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Canc J Clin"},{"key":"10.1016\/j.humpath.2021.04.008_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/000313480306901012","article-title":"Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival","volume":"69","author":"Si","year":"2003","journal-title":"Am Surg"},{"key":"10.1016\/j.humpath.2021.04.008_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.transproceed.2014.12.013","article-title":"Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience","volume":"47","author":"Varona","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.humpath.2021.04.008_bib4","first-page":"2312","article-title":"Pattern of distant extrahepatic metastases in primary liver cancer: a SEER based study","volume":"8","author":"Wu","year":"2017","journal-title":"J Canc"},{"key":"10.1016\/j.humpath.2021.04.008_bib5","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1002\/cncr.25960","article-title":"Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors","volume":"117","author":"Uchino","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.04.008_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"European association for the study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2021.04.008_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2021.04.008_bib8","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2021.04.008_bib9","first-page":"743","article-title":"Atezolizumab plus bevacizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a cost-effectiveness analysis","volume":"40","author":"Hou","year":"2020","journal-title":"Canc Commun (Lond)"},{"key":"10.1016\/j.humpath.2021.04.008_bib10","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/liv.13748","article-title":"Metastasis in patients with hepatocellular carcinoma: prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system","volume":"38","author":"Hsu","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2021.04.008_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.gtc.2017.01.009","article-title":"Morphologic subtypes of hepatocellular carcinoma","volume":"46","author":"Torbenson","year":"2017","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.humpath.2021.04.008_bib12","series-title":"WHO classification of tumours of the digestive system","year":"2019"},{"key":"10.1016\/j.humpath.2021.04.008_bib13","article-title":"Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes","author":"Torbenson","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.04.008_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12957-016-0903-8","article-title":"Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic\u00a0factors, and recent developments","volume":"14","author":"Kassahun","year":"2016","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.humpath.2021.04.008_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.29762","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance","volume":"68","author":"Ziol","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2021.04.008_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00261-018-1749-z","article-title":"Pathological variants of hepatocellular carcinoma on MRI: emphasis on histopathologic correlation","volume":"44","author":"Low","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.humpath.2021.04.008_bib17","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2021.04.008_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001289","article-title":"Macrotrabecular hepatocellular carcinoma: an aggressive subtype of hepatocellular carcinoma","volume":"43","author":"Jeon","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.04.008_bib19","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.humpath.2021.04.008_bib20","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jgh.12200","article-title":"Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation","volume":"28","author":"Han","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2021.04.008_bib21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.04.008_bib22","article-title":"FDA approval summary: atezolizumab plus bevacizumab for the treatment of patients with advanced unresectable or metastatic hepatocellular carcinoma","author":"Casak","year":"2020","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2021.04.008_bib23","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1440-1746.2005.03919.x","article-title":"Clinical features of hepatocellular carcinoma with extrahepatic metastases","volume":"20","author":"Natsuizaka","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2021.04.008_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000446245","article-title":"Clinicopathological features and metastatic pattern of hepatocellular carcinoma: an autopsy study of 398 patients","volume":"83","author":"Schlageter","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.humpath.2021.04.008_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-019-0681-x","article-title":"The Epidemiology of hepatocellular carcinoma in the USA","volume":"21","author":"Kim","year":"2019","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.humpath.2021.04.008_bib26","article-title":"Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.humpath.2021.04.008_bib27","first-page":"1395","article-title":"Prognostic significance of platelet-to-lymphocyte ratio (PLR) in extrahepatic metastasis of hepatocellular carcinoma after curative resection","volume":"13","author":"Chen","year":"2021","journal-title":"Canc Manag Res"},{"key":"10.1016\/j.humpath.2021.04.008_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000478-200201000-00003","article-title":"Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index","volume":"26","author":"Lauwers","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.04.008_bib29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12072-020-10111-4","article-title":"A standardized pathological proposal\u00a0for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC","volume":"14","author":"Sheng","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.humpath.2021.04.008_bib30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.prp.2017.03.002","article-title":"Edmondson-Steiner grade: a crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio","volume":"213","author":"Zhou","year":"2017","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2021.04.008_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-019-14050-z","article-title":"Intratumoral heterogeneity and clonal evolution in liver cancer","volume":"11","author":"Losic","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.04.008_bib32","first-page":"10495","article-title":"Genetic heterogeneity in hepatocellular carcinoma and paired bone metastasis revealed by next-generation sequencing","volume":"10","author":"Jin","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2021.04.008_bib33","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.30811","article-title":"Clinical impact of genomic diversity from early to advanced hepatocellular carcinoma","volume":"71","author":"Nault","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.humpath.2021.04.008_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203856","article-title":"Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma","volume":"13","author":"Okabe","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.humpath.2021.04.008_bib35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/1097-0142(19830201)51:3<542::AID-CNCR2820510330>3.0.CO;2-2","article-title":"Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases","volume":"51","author":"Kishi","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.04.008_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/liv.12889","article-title":"Clinicopathological indices to predict hepatocellular carcinoma molecular classification","volume":"36","author":"Tan","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.humpath.2021.04.008_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.humpath.2021.04.008_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12032-008-9130-7","article-title":"The angiogenic and prognostic implications of VEGF, Ang-1, Ang-2, and MMP-9 for hepatocellular carcinoma with background of hepatitis B virus","volume":"26","author":"Chen","year":"2009","journal-title":"Med Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:35Z","timestamp":1758645515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"alternative-id":["S0046817721000666"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.04.008","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can primary hepatocellular carcinoma histomorphology predict extrahepatic metastasis?","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}